Management Ltd Avara serves as Executive at Royalty Pharma plc, where they oversee executive responsibilities. Since joining the company, Management Ltd Avara has executed 8 insider transactions totaling $56.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 29, 2023 involved selling 65,803 shares valued at $1.8M.
Management Ltd Avara currently holds 2,477,520 shares of Royalty Pharma plc (RPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Management Ltd Avara has been a net seller of RPRX stock. They have purchased $0 and sold $56.3M worth of shares.
Management Ltd Avara's most recent insider trade was on Dec 29, 2023, when they sold 65,803 shares at $28.04 per share.
Get notified when new Form 4 filings are submitted
| $28.91 |
| Discretionary |
| Dec 13, 2023 | RPRX | $8.9M | Sale | 307,935 | $28.95 | Discretionary |
| Dec 5, 2022 | RPRX | $3.6M | Sale | 84,302 | $43.15 | Discretionary |
| Sep 28, 2022 | RPRX | $1.3M | Sale | 32,593 | $41.05 | Discretionary |
| Sep 22, 2022 | RPRX | $8.7M | Sale | 211,380 | $41.17 | Discretionary |
| Sep 8, 2022 | RPRX | $10.2M | Sale | 237,619 | $42.74 | Discretionary |
| Sep 7, 2022 | RPRX | $11.2M | Sale | 261,881 | $42.66 | Discretionary |